Primary |
Product Used For Unknown Indication |
15.3% |
Nasopharyngitis |
13.6% |
Drug Use For Unknown Indication |
12.3% |
Nasal Congestion |
8.9% |
Sinus Congestion |
8.9% |
Hypersensitivity |
5.5% |
Suicide Attempt |
4.7% |
Sinusitis |
3.8% |
Drug Exposure During Pregnancy |
3.4% |
Multiple Allergies |
3.4% |
Sinus Disorder |
3.4% |
Thyroid Disorder |
3.0% |
Hypertension |
2.6% |
Sinus Headache |
2.6% |
Rhinitis |
1.7% |
Vitamin Supplementation |
1.7% |
Asthma |
1.3% |
Headache |
1.3% |
Respiratory Tract Infection |
1.3% |
Rhinorrhoea |
1.3% |
|
Hallucination |
6.8% |
Heart Rate Increased |
6.8% |
Loss Of Consciousness |
6.8% |
Tremor |
6.8% |
Vision Blurred |
6.8% |
Convulsion |
5.1% |
Drug Exposure During Pregnancy |
5.1% |
Drug Screen Positive |
5.1% |
Off Label Use |
5.1% |
Palpitations |
5.1% |
Premature Labour |
5.1% |
Speech Disorder |
5.1% |
Suicidal Ideation |
5.1% |
Vomiting |
5.1% |
Atrial Fibrillation |
3.4% |
Dermatitis Exfoliative |
3.4% |
Drug Hypersensitivity |
3.4% |
Dysuria |
3.4% |
Haematochezia |
3.4% |
Nausea |
3.4% |
|
Secondary |
Drug Use For Unknown Indication |
20.6% |
Product Used For Unknown Indication |
12.5% |
Nasopharyngitis |
10.0% |
Nasal Congestion |
8.8% |
Migraine |
6.9% |
Sinus Congestion |
6.3% |
Sneezing |
5.9% |
Suicide Attempt |
3.1% |
Rhinorrhoea |
2.8% |
Eye Pruritus |
2.5% |
Hypersensitivity |
2.5% |
Multiple Allergies |
2.2% |
Rheumatoid Arthritis |
2.2% |
Thyroid Disorder |
2.2% |
Upper-airway Cough Syndrome |
2.2% |
Hepatitis C |
1.9% |
Ill-defined Disorder |
1.9% |
Insomnia |
1.9% |
Prophylaxis |
1.9% |
Respiratory Tract Congestion |
1.9% |
|
Vomiting |
12.7% |
Tachycardia |
10.1% |
Arthralgia |
8.9% |
Prostatitis |
8.9% |
Drug Hypersensitivity |
6.3% |
Nausea |
5.1% |
Pharmaceutical Product Complaint |
5.1% |
Sluggishness |
5.1% |
Somnolence |
5.1% |
Tendonitis |
5.1% |
Palpitations |
3.8% |
Toxic Encephalopathy |
3.8% |
Atrial Fibrillation |
2.5% |
Dermatitis Exfoliative |
2.5% |
Drug Abuse |
2.5% |
Drug Exposure During Pregnancy |
2.5% |
Dystonia |
2.5% |
Fatigue |
2.5% |
Hallucination |
2.5% |
Hypersensitivity |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
19.1% |
Drug Use For Unknown Indication |
15.1% |
Asthma |
9.2% |
Hypersensitivity |
6.6% |
Depression |
5.5% |
Anxiety |
5.4% |
Pain |
5.0% |
Headache |
4.7% |
Bronchitis |
3.0% |
Contraception |
2.9% |
Sinusitis |
2.9% |
Gastrooesophageal Reflux Disease |
2.7% |
Osteoporosis |
2.7% |
Acne |
2.5% |
Crohn's Disease |
2.4% |
Prophylaxis |
2.3% |
Seasonal Allergy |
2.2% |
Hypertension |
2.0% |
Smoking Cessation Therapy |
1.9% |
Multiple Allergies |
1.8% |
|
Vomiting |
9.9% |
Pulmonary Embolism |
8.5% |
Wound Infection Staphylococcal |
7.1% |
Nausea |
6.8% |
Ventricular Septal Defect |
6.5% |
Weight Decreased |
6.0% |
Weight Increased |
5.7% |
Drug Ineffective |
4.8% |
Pain |
4.8% |
Weight Gain Poor |
4.3% |
Rash |
4.0% |
Vitreous Floaters |
4.0% |
Drug Exposure During Pregnancy |
3.7% |
Headache |
3.7% |
Upper Respiratory Tract Infection |
3.7% |
Deep Vein Thrombosis |
3.4% |
Pruritus |
3.4% |
Tracheitis |
3.4% |
Pyrexia |
3.1% |
Suicide Attempt |
3.1% |
|
Interacting |
Asthma |
25.0% |
Multiple Allergies |
25.0% |
Smoking Cessation Therapy |
25.0% |
Trigeminal Neuralgia |
25.0% |
|
Blood Pressure Increased |
25.0% |
Presyncope |
25.0% |
Somnolence |
25.0% |
Tachycardia |
25.0% |
|